DCIS Clinical Trial
Official title:
Feasibility Study on Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for Ductal Carcinoma in Situ
In the case of a patient undergoing breast-conserving surgery for intraductal carcinoma, the sentinel lymph node is not excised during the primary surgery but only marked for identification. If the final histological examination confirms invasive cancer, delayed surgery is performed to remove the sentinel lymph node that was marked during the initial surgery. primary endpoint : The success rate of identifying the sentinel lymph node that was marked during the primary surgery in cases where the final histological examination confirms invasive cancer is evaluated.
Primary surgery: Patients diagnosed with intraductal carcinoma through histological examination and scheduled for axillary lymph node dissection are included. Prior to the surgery, blue dye and/or radioisotope injection are used to identify the sentinel lymph node, similar to the current practice. Breast-conserving surgery is performed. After identifying the sentinel lymph node in the axillary region, its location is marked using a titanium clip (size 2-4mm) or sutures. The number of marked sentinel lymph nodes is recorded for documentation. Confirmation of pathological examination results: If the final surgical specimen confirms invasive carcinoma (size > 1mm) through pathological examination, sentinel lymph node surgery is performed. Secondary surgery: Prior to the surgery, an axillary view x-ray is taken to verify the location and number of the clips. Blue dye and/or radioisotope injection is administered near the axillary incision site. Accessing the axillary region, the marked areas using clips or sutures and the detection methods of blue dye/radioisotope are used to identify the sentinel lymph node for sentinel lymph node biopsy. The number of removed clips/sutures and the number of sentinel lymph nodes identified are documented for record keeping. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00256217 -
Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT03931928 -
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
|
Phase 2 | |
Terminated |
NCT03535506 -
Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery
|
Phase 2 | |
Recruiting |
NCT04797299 -
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
|
||
Completed |
NCT02637024 -
Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation
|
Phase 2 | |
Completed |
NCT00148655 -
Educational Interventions for Patients With DCIS
|
N/A | |
Suspended |
NCT03936478 -
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
|
Phase 2 | |
Recruiting |
NCT03878342 -
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast
|
N/A | |
Recruiting |
NCT03793829 -
Neoadjuvant Multi-epitope HER2 Peptide Vaccine in Patients With HER2-expressing DCIS
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04245150 -
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
|
||
Recruiting |
NCT06388304 -
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence
|
N/A | |
Not yet recruiting |
NCT06217458 -
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
|
N/A | |
Recruiting |
NCT04722692 -
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
|
Phase 3 | |
Enrolling by invitation |
NCT05868252 -
Molecular Analysis of the Sloane Project
|
||
Recruiting |
NCT04049214 -
Perioperative Mindfulness Proposal
|
N/A | |
Completed |
NCT02061332 -
DC Vaccine for Patients With Ductal Carcinoma In Situ
|
Phase 1/Phase 2 | |
Recruiting |
NCT04916808 -
The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing
|
||
Withdrawn |
NCT05436808 -
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer
|
Early Phase 1 | |
Recruiting |
NCT05900986 -
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
|
Phase 1/Phase 2 | |
Suspended |
NCT03448926 -
The PREDICT Registry for DCIS Patients With DCISionRT Testing
|